The CRISPR ancillary effector Can2 is a dual-specificity nuclease potentiating type III CRISPR defence.

MLA

Zhu, Wenlong, et al. “The CRISPR Ancillary Effector Can2 Is a Dual-Specificity Nuclease Potentiating Type III CRISPR Defence.” Nucleic Acids Research, vol. 49, no. 5, Mar. 2021, pp. 2777–89. EBSCOhost, https://doi.org/10.1093/nar/gkab073.

APA

Zhu, W., McQuarrie, S., Grüschow, S., McMahon, S. A., Graham, S., Gloster, T. M., & White, M. F. (2021). The CRISPR ancillary effector Can2 is a dual-specificity nuclease potentiating type III CRISPR defence. Nucleic Acids Research, 49(5), 2777–2789. https://doi.org/10.1093/nar/gkab073

Chicago

Zhu, Wenlong, Stuart McQuarrie, Sabine Grüschow, Stephen A McMahon, Shirley Graham, Tracey M Gloster, and Malcolm F White. 2021. “The CRISPR Ancillary Effector Can2 Is a Dual-Specificity Nuclease Potentiating Type III CRISPR Defence.” Nucleic Acids Research 49 (5): 2777–89. doi:10.1093/nar/gkab073.